TABLE 4.
Adverse events in the study a .
| Event | Acetaminophen (n = 116) | Placebo (n = 119) | p value |
|---|---|---|---|
| Severe adverse events, n/total N (%) | 3/116 (3%) | 1/119 (0.8%) | 0.37 |
| Postoperative infection | 1/116 (0.9%) | 0/119 (0%) | |
| Scrotal hematoma | 1/116 (0.9%) | 0/119 (0%) | |
| Reperfusion-induced injury | 1/116 (0.9%) | 0/119 (0%) | |
| Intraoperative hypotension | 0/116 (0%) | 1/119 (0.8%) | |
| Adverse events, n/total N (%) | |||
| Fever | 31/116 (27%) | 39/119 (33%) | 0.32 |
| Postoperative nausea and vomiting | 25/116 (22%) | 28/119 (24%) | 0.70 |
| Anemia | 17/116 (15%) | 20/119 (17%) | 0.72 |
| Dizziness | 8/116 (7%) | 10/119 (8%) | 0.81 |
| Hypoproteinemia | 6/116 (5%) | 9/119 (8%) | 0.60 |
| Decreased appetite | 6/116 (5%) | 9/119 (8%) | 0.60 |
a
Only adverse events occurring in at least 5% of patients in either group are shown.